Previous Article | Next Article ![]()
Infection and Immunity, May 2001, p. 3335-3342, Vol. 69, No. 5
Department of
Pediatrics1 and Department of
Pathology,2 University of Rochester School
of Medicine and Dentistry, Rochester, New York 14642
Received 13 November 2000/Returned for modification 8 January
2001/Accepted 29 January 2001
From five mice immunized with Escherichia coli K1
bacteria, we produced 12 immunoglobulin M hybridomas secreting
monoclonal antibodies (MAbs) that bind to Neisseria
meningitidis group B (NMGB). The 12 MAbs also bound the
capsular polysaccharide (PS) of E. coli K1 [which, like
NMGB, is
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3335-3342.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Monoclonal Antibodies Specific for Neisseria
meningitidis Group B Polysaccharide and Their Peptide
Mimotopes

(2-8)-linked polysialic acid (PSA)] and bound to EV36, a
nonpathogenic E. coli K-12 strain producing
(2-8)
PSA. Except for HmenB5, which cross-reacted with N.
meningitidis group C, none of the MAbs bound to N.
meningitidis groups A, C, and Y. Of the 12 MAbs, 6 were
autoantibodies as defined by binding to CHP-134, a neuroblastoma cell
line expressing short-chain
(2-8) PSA; five of these MAbs
killed NMGB in the presence of rabbit complement, and two also
killed NMGB with human complement. The other six MAbs, however, were
nonautoreactive; all killed NMGB with rabbit complement, and five
killed NMGB with human complement. To obtain peptide mimotopes of NMGB
PS, four of the nonautoreactive MAbs (HmenB2, HmenB3, HmenB13, and
HmenB14) were used to screen two types of phage libraries, one with a
linear peptide of 7 amino acids and the other with a circular peptide
of 7 amino acids inserted between two linked cysteines. We obtained 86 phage clones that bound to the screening MAb in the absence but not in
the presence of E. coli K1 PSA in solution. The clones
contained 31 linear and 4 circular mimotopes expressing unique
sequences. These mimotopes nonrandomly expressed amino acids
and were different from previously described mimotopes for NMGB PS. The
new mimotopes may be useful in producing a vaccine(s) capable of
eliciting anti-NMGB antibodies not reactive with neuronal tissue.
*
Corresponding author. Mailing address: University of
Rochester School of Medicine and Dentistry, Departments of Pediatrics and Pathology, 601 Elmwood Ave., Box 608, Rochester, NY
14642. Phone: (716) 273-4157. Fax: (716) 273-1101. E-mail:
moon_nahm{at}urmc.rochester.edu.
Present address: Department of Microbiology, College of Medicine,
Yonsei University, Seoul (120-752), Korea.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»